Endothelial Cell Seeding on Crosslinked Collagen: Effects of Crosslinking on Endothelial Cell Proliferation and Functional Parameters

Summary

Endothelial cell seeding, a promising method to improve the performance of small-diameter vascular grafts, requires a suitable substrate, such as crosslinked collagen. Commonly used crosslinking agents such as glutaraldehyde and formaldehyde cause, however, cytotoxic reactions and thereby hamper endothelialization of currently available collagen-coated vascular graft materials.

The aim of this study was to investigate the effects of an alternative method for crosslinking of collagen, using N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide (EDC) in combination with N-hydroxysuccinimide (NHS), on various cellular functions of human umbilical vein endothelial cells (HUVECs) in vitro. Compared to non-crosslinked type I collagen, proliferation of seeded endothelial cells was significantly increased on EDC/NHS-crosslinked collagen. Furthermore, higher cell numbers were found with increasing crosslink densities. Neither the morphology of the cells nor the secretion of prostacyclin (PGI₂), von Willebrand factor (vWF), tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) was affected by the crosslink density of the collagen substrate. Therefore, EDC/NHScrosslinked collagen is candidate substrate for in vivo application such as endothelial cell seeding of collagen-coated vascular grafts.

Key words

Vascular grafts - collagen crosslinking - endothelial cell seeding - endothelial cell function

• References

• 1 Pevec WC, Darling RC, L’Italien GJ, Abbot WM. Femoropopliteal reconstruction with knitted nonvelour Dacron versus expanded polytetrafluoroethylene. J Vasc Surg 1992; 16: 60-5.
• 2 Wilson YG, Wyatt MG, Currie IC, Baird RN, Lamont PM. Preferential use of vein for above-knee femoropopliteal grafts. Eur J Vasc Endovasc Surg 1995; 10: 220-5.
• 3 Koch G, Gutschi S, Pascher O, Fruhwirth J, Hauser H. Femoropopliteal vascular replacement: Vein, ePTFE or ovine collagen?. Zentralbl Chir 1996; 121: 761-7.
• 4 Watelet J, Soury P, Menard JF, Plissonnier D, Peillon C, Lestrat JP, Testart J. Femoropopliteal bypass: In situ or reversed vein grafts? Ten-year results of a randomized prospective study. Ann Vasc Surg 1997; 11: 510-9.
• 5 Herring MB. Vascular grafting. Clinical applications and techniques. Wright CB, Hobson RW, Hiratzka LF, Lynch TG. Boston: John Wright; 1983: 275-314.
• 6 Dekker A, Reitsema K, Beugeling T, Bantjes A, Feijen J. Adhesion of endothelial cells and adsorption of serum proteins on gas plasma treated polytetrafluoroethylene. Biomaterials 1991; 12: 130-7.
• 7 Schor AM, Schor SL, Kumar S. Importance of a collagen substratum for stimulation of capillary endothelial cell proliferation by tumor angiogenesis factor. Int J Cancer 1979; 24: 225-34.
• 8 Delvos U, Gajdusek C, Sage H, Harker LA, Swartz SM. Interactions of vascular wall cells with collagen gels. Lab Invest 1982; 46: 61-72.
• 9 Sato K, Taira T, Takayama R, Ohtsuki K, Kawabata M. Improved chromatographic purification of human and bovine type V collagen sub-molecular species and their subunit chains from conventional crude preparations. Application to cell-substratum assays for human umbilical vein endothelial cell. J Chromatogr 1995; 663: 25-33.
• 10 Hofman H, Schankereli K. Synthetic vascular grafts with collagen envelopes. US 84 575082 (1984 patent, 21 pages).
• 11 Weadock KS, Goggins JA. Vascular graft sealants. J Long Term Effects of Medical Implants 1993; 03: 207-22.
• 12 Olde LHHDamink, Dijkstra PJ, van Luyn MJA, van Wachem PB, Nieuwenhuis P, Feijen J. Glutaraldehyde as a crosslink agent for collagenbased biomaterials. J Mat Sci: Mat Med 1995; 06: 460-72.
• 13 Gendler E, Gendler S, Nimni ME. Toxic reactions evoked by glutaraldehyde fixed pericardium and cardiac valve tissue bioprosthesis. J Biomed Mat Res 1984; 18: 727-36.
• 14 Eyble E, Griesmacher A, Grimm M, Wolner E. Toxic effects of aldehydes released from fixed pericardium on bovine aortic endothelial cells. J Biomed Mat Res 1989; 23: 1355-69.
• 15 Huang-Lee LLH, Cheung DT, Nimni ME. Biochemical changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived crosslinks. J Biomed Mat Res 1990; 24: 1185-201.
• 16 van Luyn MJA, van Wachem PB, Olde LHHDamink, Dijkstra PJ, Feijen J. Relations between in vitro cytotoxicity and crosslinked dermal sheep collagens. J Biomed Mat Res 1992; 26: 1091-110.
• 17 Bengtsson L, Ragnarson B, Haegerstrand A. Lining of viable and nonviable allogenic and xenogenic cardiovascular tissue with cultured adult human venous endothelium. J Thorac Cardiovasc Surg 1993; 106: 434-43.
• 18 Rich DH, Sing J. In: The peptides. Gross E, Meinenhofer J. eds. New York: Academic Press; 1982: 242-63.
• 19 Lundblad RL. Chemical reagents for protein modification. Ann Arbor: CRC Press; 1991
• 20 Gilles MA, Hudson AQ, Borders CL. Stability of water-soluble carbodiimides in aqueous solutions. Anal Biochem 1990; 184: 244-8.
• 21 Besselink GAJ, Beugeling T, Bantjes A. N-Hydroxysuccinimide-activated glycine-sepharose. Appl Biochem Biotech 1993; 43: 227-46.
• 22 Wang CL, Miyata T, Wecksler B, Rubin AL, Stenzel KH. Collagen induced platelet aggregation and release. I. Effects of the side-chain modifications and role of argynyl residues. Biochim Biophys Acta 1978; 544: 555-67.
• 23 Gilbert DL, Kim SW. Macromolecular release from collagen monolithic devices. J Biomed Mat Res 1990; 24: 1221-39.
• 24 Loke WK, Khor E. Validation of the shrinkage temperature of animal tissue for bioprosthetic heart valve application by differential scanning calorimetry. Biomaterials 1995; 16: 251-8.
• 25 van Wachem PB, Reinders JH, van Buul-Wortelboer MF, de Groot PG, van Aken WG, Mourik JA. Von Willebrand factor in cultured human vascular endothelial cells from adult and umbilical cord arteries and veins. Thromb Haemost 1986; 56: 189-92.
• 26 Meijer P, Pollet DE, Wauters J, Kluft C. Specificity of antigen assay of plasminogen activator inhibitor in plasma: Innotest PAI-1 immunoassay evaluated. Clin Chem 1994; 40: 110-15.
• 27 Favaloro EJ, Grispo L, Dinale A, Berndt M, Koutts J. Von Willebrand’s disease: Laboratory investigation using an improved functional assay for von Willebrand factor. Pathology 1993; 25: 152-5.
• 28 Fitzpatrick FA. In: Prostacyclin. Vane JR, Bergstrom S. eds. New York: Raven Press; 1979: 55-64.
• 29 Yannas IV. Materials for skin and nerve regeneration: Biological analogues of the extracellular matrix. Mat Sci Tech 1992; 14: 179-208.
• 30 Bentsson L, Ragnarson B, Haegerstrand A. Lining of viable and nonviable allogenic and xenogenic cardiovascular tissue with cultured adult human venous endothelium. J Thorac Cardiovasc Surg 1993; 106: 434-43.
• 31 van Wachem PB, van Luyn MJA, Olde LHHDamink, Dijkstra PJ, Feijen J, Nieuwenhuis P. Tissue regenerating capacity of carbodiimide-crosslinked dermal sheep collagen during repair of the abdominal wall. Biomaterials 1994; 17: 230-9.
• 32 van Wachem PB, van Luyn MJA, Olde LHHDamink, Dijkstra PJ, Nieuwenhuis P. Biocompatibility and tissue regenerating capacity of crosslinked dermal sheep collagen. J Biomed Mat Res 1994; 28: 353-63.
• 33 van Luyn MJA, van Wachem PB, Dijkstra PJ, Olde LHHDamink, Feijen J. Calcification of subcutaneously implanted collagens in relation to cytotoxicity, cellular interactions and crosslinking. J Mat Sci: Mat Med 1995; 06: 288-96.
• 34 Dekker A, Pennartz G, Metzger M, Valdor M, Pidun B, Mittermayer C, Kirkpatric CJ. Secretion of tissue type plasminogen activator, plasminogen activator inhibitor, prostaglandin I2 and von Willebrand factor by human endothelial cells: Influence of cell density. VIIth International symposium on the biology of vascular cells. Heidelberg; Germany: 1994
• 35 Boutherin-Falson O, Blaes N. Decreased prostacyclin production by human umbilical vein endothelial cells cultured with endothelial cell growth factor and heparin. Thromb Res 1989; 54: 487-92.
• 36 Penhoat J, Sigot-Luizard MF, Warocquier-Clerout R. Prostacyclin secretion by human endothelial cells grown on carbodiimide crosslinked proteins: An assessment of the cytocompatibility of a substratum. Biomaterials 1993; 14: 503-6.
• 37 Wissink MJB, Beernink R, Poot AA, Engbers GHM, Beugeling T, van Aken WG, Feijen J. Relation between cell density and the secretion of von Willebrand factor and prostacyclin by human umbilical vein endothelial cells. Accepted for publication in Biomaterials.